Biphasic effect of apomorphine on rat nociception and effect of dopamine D2 receptor antagonists
Author
dc.contributor.author
Pelissier Serrano, Teresa
Author
dc.contributor.author
Laurido, Claudio
Author
dc.contributor.author
Hernández, Alejandro
Author
dc.contributor.author
Constandil, Luis
Author
dc.contributor.author
Eschalier, Alain
Admission date
dc.date.accessioned
2019-03-11T12:51:20Z
Available date
dc.date.available
2019-03-11T12:51:20Z
Publication date
dc.date.issued
2006
Cita de ítem
dc.identifier.citation
European Journal of Pharmacology, Volumen 546, Issue 1-3, 2018, Pages 40-47
Identifier
dc.identifier.issn
00142999
Identifier
dc.identifier.other
10.1016/j.ejphar.2006.06.081
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164191
Abstract
dc.description.abstract
Studies on the effect of dopaminergic agonists in behavioral measures of nociception have gathered numerous but rather conflicting data. We studied the effects of the D1/D2 receptor agonist apomorphine, as well as the modulatory effects of (S)-(-)-sulpiride (selective D2 receptor antagonist) and domperidone (peripheral D2 receptor antagonist), on thermal, mechanical and chemical nociception on rats. Apomorphine induced a biphasic dose-response relationship, low doses producing hyperalgesia and high doses inducing antinociception. Tonic (chemical) pain was more sensitive to apomorphine than phasic (thermal and mechanical thresholds) pain. (S)-(-)-sulpiride, but not domperidone, fully antagonized the antinociceptive effect of apomorphine in all three measures of nociception, pointing to a participation of D2 dopaminergic receptors for the antinociceptive action of apomorphine. Although spinal sites for dopaminergic ligands mechanistically may account for the effects observed, involvement